These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 314334)

  • 1. Effect of local immunotherapy of syngeneic rat fibrosarcoma with hapten and antihapten-tumor serum upon nonlocally treated tumor.
    Arai K; Wallace HW
    Cancer Res; 1979 Sep; 39(9):3638-43. PubMed ID: 314334
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma.
    Arai K; Spencer JS; Sohn M; Wallace HW
    Cancer Res; 1979 Jan; 39(1):6-16. PubMed ID: 310708
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of anti-hapten serum on hapten-treated rat tumor.
    Wallace HW; Arai K
    Surg Forum; 1978; 29():126-8. PubMed ID: 401112
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor effects of antibody-diphtheria toxin conjugates: use of hapten-coated tumor cells as an antigenic target.
    Moolten FL; Capparell NJ; Cooperband SR
    J Natl Cancer Inst; 1972 Oct; 49(4):1057-62. PubMed ID: 4343471
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.
    Ogura T; Namba N; Hirao F; Yamamura Y; Azuma I
    Cancer Res; 1979 Nov; 39(11):4706-12. PubMed ID: 498096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of effective timing for combination treatment with chemotherapy and immunotherapy against a transplantable tumor in rats.
    Gotohda E
    Hokkaido Igaku Zasshi; 1977 May; 52(3):265-74. PubMed ID: 21133
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of modified tumor antigen on experimentally induced sarcomas.
    Nigam SK; Bhatt VH
    Saudi Med J; 2001 Feb; 22(2):157-63. PubMed ID: 11299413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of immunotherapy and chemotherapy to experimental tumors in rats.
    Hosokawa M; Sendo F; Gotoda E; Kobayashi H
    Gan; 1971 Feb; 62(1):57-60. PubMed ID: 5553381
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
    Vaage J
    Cancer Res; 1971 Nov; 31(11):1655-62. PubMed ID: 5121668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study for active specific immunotherapy and immunochemotherapy using 3M KC1 solubilized tumor].
    Kobayashi M
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2112-25. PubMed ID: 4093687
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats.
    Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 17. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
    So SK; Song CW; Rios A; Simmons RL
    J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. I. Adaptation of the virus to mouse tumour cells as a pre-requisit for adjuvanticity.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):1-8. PubMed ID: 757683
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of Bacillus Calmette-Guérin-induced suppression of metastases in a poorly immunogenic fibrosarcoma.
    Liotta LA; Kleinerman J; Saidel GM
    Cancer Res; 1976 Sep; 36(9 pt.1):3255-9. PubMed ID: 788897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.